Division of Urology, Departments of Surgery, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS , Sherbrooke , Quebec , Canada.
Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network , Toronto , Ontario , Canada.
J Urol. 2019 Aug;202(2):319-325. doi: 10.1097/JU.0000000000000213. Epub 2019 Jul 8.
Patients with bladder cancer who undergo intestinal urinary diversion may be at increased risk for bone fractures thought to be secondary to chronic metabolic acidosis and ensuing bone loss. Our main objective was to assess whether patients who undergo intestinal urinary diversion are at increased risk for fracture.
Patients who underwent intestinal urinary diversion between 1994 and 2014 in Ontario, Canada were identified using linked administrative databases. Patients were categorized as undergoing diversion for bladder cancer or nonbladder cancer causes and matched 4:1 to a healthy cohort. We determined incidence rates of the incidence of fractures per 100 person-years. Multivariable Cox proportional hazards models were used to evaluate the impact of intestinal urinary diversion on the risk of fracture.
Overall 4,301 patients with and 907 without bladder cancer underwent intestinal urinary diversion. The fracture incidence rate was significantly greater in the bladder cancer and nonbladder cancer cohorts compared to respective matched controls. In the bladder cancer cohort vs matched controls there were 4.41 vs 2.63 fractures per 100 person-years and in the nonbladder cancer cohort vs matched controls there were 5.67 vs 3.51 fractures per 100 person-years (each p <0.001). On multivariable analysis patients who underwent intestinal urinary diversion for bladder cancer or nonbladder cancer reasons had significantly shorter fracture-free survival compared to the respective matched cohorts (HR 1.48, IQR 1.35-1.63, and HR 1.48, IQR 1.31-1.69, respectively).
Our results demonstrated that regardless of age patients with intestinal urinary diversion are at increased risk for bone fractures compared to the general population. Our findings are in line with previous reports and support the need for bone health monitoring.
接受肠尿路转流术的膀胱癌患者可能由于慢性代谢性酸中毒和随后的骨丢失而导致骨折风险增加。我们的主要目的是评估接受肠尿路转流术的患者是否有更高的骨折风险。
在加拿大安大略省,通过链接的行政数据库确定了 1994 年至 2014 年间接受肠尿路转流术的患者。患者分为因膀胱癌或非膀胱癌原因接受转流术的患者,并与 4:1 的健康队列相匹配。我们确定了每 100 人年骨折发生率。多变量 Cox 比例风险模型用于评估肠尿路转流术对骨折风险的影响。
共有 4301 例膀胱癌患者和 907 例非膀胱癌患者接受肠尿路转流术。与各自的匹配对照组相比,膀胱癌和非膀胱癌队列的骨折发生率显著更高。在膀胱癌队列中,与匹配对照组相比,骨折发生率为每 100 人年 4.41 例和 2.63 例,在非膀胱癌队列中,与匹配对照组相比,骨折发生率为每 100 人年 5.67 例和 3.51 例(均<0.001)。在多变量分析中,与各自的匹配队列相比,因膀胱癌或非膀胱癌原因接受肠尿路转流术的患者骨折无事件生存率显著缩短(HR 1.48,IQR 1.35-1.63,和 HR 1.48,IQR 1.31-1.69,分别)。
无论年龄大小,与普通人群相比,接受肠尿路转流术的患者骨折风险均增加。我们的研究结果与之前的报告一致,支持对骨骼健康进行监测。